10-Q: Quarterly report pursuant to Section 13 or 15(d)

Exhibit 4.4

FIFTH SUPPLEMENTAL INDENTURE

(Senior Notes due 2025)

THIS FIFTH SUPPLEMENTAL INDENTURE (this “Fifth Supplemental Indenture”) is dated as of August 4, 2015, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

W I T N E S S E T H :

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of September 11, 2014 (as supplemented by that First Supplemental Indenture, dated as of November 25, 2014, that Second Supplemental Indenture, dated as of January 23, 2015, that Third Supplemental Indenture, effective as of March 2, 2015 and that Fourth Supplemental Indenture, dated as of April 1, 2015; the “Indenture”), providing for the issuance of the Issuer’s 4.50% Senior Notes due 2025 (the “Notes”);

WHEREAS, Section 9.01 of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of making any change that would not materially adversely affect the rights of any Holder of the Notes;

WHEREAS, pursuant to Section 4.14 and/or 5.01(b) of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture to be duly executed, all as of the date first above written.

[Signatures continued on the following page]

[Signatures continued on the following page]

Schedule I

SUBSIDIARY GUARANTORS

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

[Schedule I – 5^th Supplemental Indenture – 2027 Notes]

Schedule II

NEW SUBSIDIARIES

[Schedule II – 5^th Supplemental Indenture – 2027 Notes]